CaryHealth Launches Direct-to-Patient Platform to Transform Access to Natroba™ (Spinosad)
CaryHealth, a leading innovator in digital health solutions, has announced the launch of its new direct-to-patient (DTP) platform designed to streamline and enhance patient access to Natroba™ (spinosad). This prescription medication, developed and marketed in partnership with Cipher Pharmaceuticals US LLC, is widely used for the treatment of head lice and scabies—two highly common and often frustrating conditions affecting families worldwide.
The newly introduced platform represents a significant shift in how patients access treatment, aiming to eliminate inefficiencies and barriers that are often associated with traditional and even virtual healthcare systems. By prioritizing a patient-first approach, CaryHealth seeks to deliver a seamless, end-to-end healthcare experience that integrates consultation, prescription, fulfillment, and delivery into a single cohesive system.
A New Era of Patient-Centric Healthcare
The CaryHealth DTP platform has been specifically designed to modernize the patient journey. Traditionally, patients seeking treatment for conditions like head lice or scabies must navigate a fragmented process involving multiple steps—consulting healthcare providers, obtaining prescriptions, visiting pharmacies, and dealing with delays in medication access. Even virtual care solutions, while more convenient, often involve disconnected systems, multiple logins, and separate payment processes.
CaryHealth’s platform addresses these pain points by offering a unified digital solution that simplifies the entire workflow. Patients can now access telehealth consultations, receive clinically appropriate prescriptions, and arrange for medication delivery or local pickup—all within a single interface.
This integrated approach significantly reduces the time between diagnosis and treatment, ensuring that patients—especially families dealing with contagious conditions—can act quickly and effectively.
Tackling Common Conditions with Greater Efficiency
Head lice and scabies are not only uncomfortable but also highly contagious, often spreading rapidly within households, schools, and communities. Quick and effective treatment is essential to prevent further transmission and minimize disruption to daily life.
Natroba™ (spinosad) has emerged as a trusted prescription solution for these conditions, offering clinically proven effectiveness. However, access to prescription treatments has historically been a challenge due to delays, limited availability, or reliance on over-the-counter products that may not deliver desired results.
According to Bryan Jacobs, President of U.S. Operations at Cipher Pharmaceuticals, the partnership with CaryHealth aims to address these challenges directly:
Families suffering from head lice and scabies need a fast yet simple solution to access the best and most effective prescription available. By partnering with CaryHealth, we are making it easier for patients to quickly get Natroba™, or its authorized generic spinosad, through local pick-up or delivery options.”
He further emphasized that many over-the-counter treatments available in pharmacy aisles are no longer as effective, making prescription solutions like Natroba™ increasingly important in managing these conditions promptly and successfully.
Seamless Integration of Care and Technology
One of the most notable aspects of CaryHealth’s DTP platform is its ability to integrate multiple components of the healthcare journey into one streamlined experience. This includes:
- Telehealth Access: Patients can consult licensed healthcare providers online to determine if Natroba™ (spinosad) is appropriate for their condition.
- E-Prescribing: Prescriptions are issued digitally, eliminating the need for paper-based processes.
- Pharmacy Fulfillment: The platform connects directly with pharmacies to ensure quick and reliable dispensing of medication.
- Delivery or Pickup Options: Patients can choose between convenient home delivery or local pharmacy pickup, depending on their preference and location.
- Real-Time Tracking: Through the CaryConnect portal, users can monitor the status of their prescriptions from consultation to delivery.
This level of integration not only improves convenience but also enhances transparency and patient confidence throughout the treatment process.
Eliminating Barriers in Virtual Care
While telehealth has grown rapidly in recent years, many virtual care platforms still suffer from fragmented workflows. Patients often encounter multiple systems that do not communicate effectively, leading to confusion, delays, and frustration.
CaryHealth’s DTP model eliminates these inefficiencies by creating a unified ecosystem. Instead of navigating separate platforms for consultations, prescriptions, and payments, patients can complete every step within a single, intuitive interface.
Areo Nazari, CEO of CaryHealth, highlighted the significance of this innovation:
Cipher is taking a bold and patient-centered step by investing in a unified, digital-first access model. By integrating prescribing, clinical engagement, and pharmacy fulfillment—including delivery—into one cohesive experience, we can help families return to normal life from the moment they seek care through successful treatment.”
This approach reflects a broader shift in healthcare toward digital transformation and patient empowerment, where convenience and accessibility are key priorities.
Faster Treatment, Better Outcomes
Time is a critical factor when dealing with contagious conditions like head lice and scabies. Delays in treatment can lead to further spread, prolonged discomfort, and increased stress for patients and their families.
By reducing the time required to access medication, CaryHealth’s platform plays a crucial role in improving health outcomes. Patients can move quickly from symptom recognition to effective treatment, minimizing the impact of the condition on their daily lives.
Additionally, the platform’s ability to provide same-day delivery in select CaryRx geographies ensures that patients receive their medication as soon as possible. This rapid response capability is particularly valuable for families managing outbreaks in school or household settings.
Enhancing the Patient Journey End-to-End
CaryHealth’s DTP platform is not just about convenience—it’s about reimagining the entire patient journey. From the initial search for care to the completion of treatment, every step has been optimized to reduce friction and improve the overall experience.
Key benefits include:
- Reduced Administrative Burden: Fewer forms, logins, and manual processes.
- Improved Accessibility: Easier access to prescription treatments regardless of location.
- Greater Transparency: Real-time updates and clear communication at every stage.
- Enhanced Patient Engagement: A more intuitive and user-friendly digital interface.
By focusing on these elements, CaryHealth aims to set a new standard for how healthcare services are delivered in the digital age.
A Strategic Partnership Driving Innovation
The collaboration between CaryHealth and Cipher Pharmaceuticals underscores the growing importance of partnerships in advancing healthcare innovation. By combining CaryHealth’s digital expertise with Cipher’s pharmaceutical capabilities, the two companies are able to deliver a comprehensive solution that addresses both clinical and logistical challenges.
This partnership also reflects a shared commitment to patient-centered care, where the primary goal is to improve access, outcomes, and overall satisfaction.
Looking Ahead: The Future of Direct-to-Patient Healthcare
The launch of CaryHealth’s DTP platform for Natroba™ (spinosad) represents a significant milestone in the evolution of healthcare delivery. As more patients and providers embrace digital solutions, platforms like this are likely to become increasingly common.
Looking ahead, the success of this initiative could pave the way for similar models across other therapeutic areas, further expanding access to essential medications and services.
By prioritizing simplicity, speed, and integration, CaryHealth is positioning itself at the forefront of a healthcare transformation that puts patients first.
CaryHealth’s direct-to-patient platform marks a major step forward in addressing the challenges associated with accessing prescription treatments for common conditions like head lice and scabies. Through its partnership with Cipher Pharmaceuticals, the company has created a seamless, digital-first solution that eliminates barriers, accelerates treatment, and enhances the overall patient experience.
As healthcare continues to evolve, innovations like this highlight the potential of technology to improve lives—making care more accessible, efficient, and patient-centered than ever before.
About CaryHealth
CaryHealth is an AI-enabled digital pharmacy and healthcare technology company redefining how patients start and stay on therapy. Our platform unites pharmacy services, intelligent automation, and data-driven engagement to simplify access, improve continuity of care, and empower patients throughout their treatment journey. By bridging the gap between life sciences, providers, and patients, CaryHealth advances equitable access and helps therapies reach their full potential.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher’s topical product Natroba™, and its authorized generic spinosad, is the only product that carries the U.S. Food and Drug Administration’s (FDA’s) “Complete Cure” designation for the treatment scabies. 1 Additionally, Natroba™ (spinosad) is the only FDA approved prescription head lice treatment that demonstrated clinical superiority to Nix® (permethrin 1%) in two head-to-head, phase III clinical trials. No nit combing required.
